Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you.
Thanks for posting. Travel safe.
Agreed. A long slog, a slow pay off if milestones can be achieved and revenue can be earned. I've stayed fast because I believe Diwan can get it done. Shelton is the promise land. Reaching the current production milestone was very important. One longstanding concern has been achieving productization. While we're not quite where we need to be to support commercial production we've crossed a major threshold.
Good luck and safe travels for any braving the weather to attend today's shareholder's meeting.
Thanks for your report from the conference and follow up posts.
Thank you for your recap.
Thank you for sharing your observations.
The Pharma can sign a deal anytime they wish. They can sign a deal for an idea on the back of a napkin if they wish. It is not in CTIX's interest or the "best" interest of the shareholders to sign a deal until FDA approval is granted. Deal from a position of strength. Hold off deals until the best conditions exist.
Happy Thanksgiving. GLTA longs. Thankful to put 2015 behind us. Looking forward to 2016, recognizing benefits from the dedicated efforts of Drs. Diwan, Seymour and the expanding staff in Shelton.
Happy Thanksgiving CTIX shareholders. I'm thankful to the many posters who contribute to the board, improving my understanding of this wonderful investment opportunity. GLTA. Good luck to those who may benefit from CTIX drugs for years to come.
Pleased to have an old IEVM hand grace us with a sell recommendation in his first post to the board. Thanks. I'll sell when the market opens tomorrow.
Post of the week.
I got behind the wheel in 2009, sober. I don't see a Good Samaritan. I do feel someone hand in my pocket. It wouldn't be the first time a victim's pocket was picked.
Keep polishing your halo.
People who slow to look at an automobile accident don't mock and heap ridicule on the victims.
Unfortunately, true.
Interesting activity today, particularly that it is a Friday. We're due for additional wells update. I'll be looking for that next week.
Oh, snap!
You are incorrect. Nanoviricides has been deleted from the R3K.
I can't say I know of an instance where one company pays the salary of another's President. That said, I have paid the salaries of hundreds of individuals employed by companies I've contracted to provide services to my company. It is common practice in contracts between firms to earmark funds for the satisfaction of staff costs for a contracted service suppliers. In the case of TC the CEO happens also to be an essential participant in the design and engineering efforts contracted by NNVC.
I substitute Yankees for Cubs but apart from that I like your prescription.
Thank you. You might consider citing the consulting and contracting firms involved in design build out.
I fully agree. Long play.
There's no evidence to substantiate your claims.
I remain a shareholder and have confidence that IEVM will continue to increase revenue growth.
MSU= ignored.
Thank you.
JG35,
Is this in reply to a post from the NNVC board? I can't find the original.
Thanks for the clarification. I thought Drano was referencing another poster; Total-Blathering-Idiocy-Again.
It is admittedly a disquieting pattern for this Long. I can't imagine the pattern not inducing anxiety in even the most committed Longs. (I've been in since 2009. There are others, active on this board until recently and perhaps still invested who have been holding out hope for a greater number of years.) To read some of the Bears on this board you might think Bulls are Pollyanna about NanoViricides' performance. Not true in this Long's case. I'm an uncertain investor in a number of small, developing companies. (All investors should be.) Does this mean I should not invest in emerging companies? I know the risk. I accept the risk. I'm diversified. My life and lifestyle will not change if NanoViricides disappoints.
NanoViricides has been unable (is perhaps on the verge of being able), to produce Viricides in volume. In light of this limitation they have been limited to dabbling in a wide variety of viral playgrounds. They have been limited to dipping toes and toiling on the shoreline while competitors immerse themselves in the deep water. Unfocused? Misdirected? Or, exploring where possible with limited capacity manufacturing in an effort to validate the science and the platform's versatility? I tend towards the latter but have entertained the alternatives on more than one occasion. (If they can't produce in volume sufficient for BASi tox until Shelton is fully operational and scale-up is achieved should they sit on their hands? I'd rather Dr. Diwan and his team continue exploring and improving formulations.
True, NanoViricides has conducted preliminary experimentation with remedies for Herpes, Rabies, HIV, MERS, Dengue, Ebola and Influenza. And in these preliminary experiments results have shown promise. This Long is betting on the promise. Further, toxicity has been demonstrated to be virtually nonexistent. This Long is emboldened by these preliminary too results.
Unfortunately for NanoViricides (and its shareHOLDERS), the result of experiments to date have been informally reported and therefore suspect. As well, toxicity results, with the exception of 2014 BASi prelims, have come from internal or KARD testing and therefore have been received with skepticism. And are vulnerable to criticism. There are many more promising and derisked bio pharmaceutical start-up for institutional investors and potential Big Pharma partners to pursue.
So, this investment remains high risk with potential high reward. This Long is holding.
The myth of the "lifestyle" company explodes once you've crossed the threshold of the old facility. Nanoviricides capital is not being squandered on Management extravagance. Our investment dollars are going into the science and the company's slow but steady progress.
Wow, a picture portraying the old facility as inactive and abandoned. I better sell my shares.
But wait, I've done my DD. I've toured both the old and new facility. I've spoken to the good Drs. I've investigated the science ( to the best of my ability), and weighed the commitment and honesty of the Management team. I'm still long.
Every picture tells a story, baby. (About the photographer or curator.)
Thanks again for a strong series of posts. You consistently provide enlightening and substantive arguments.
I don't know what TTPH did to merit today's action I only hope it's contagious and the rest of my portfolio catches it.
Thanks for the reply.
Another fine post. If readers were to take your words to heart the exchange of posts on this board and others would undoubtedly be elevated.
Thank you. That makes sense.
Thanks for posting your interpretation. I don't follow your last statement. What "element that's real" are you referring to?
A first hand account of the presentation and Q/A session from you would be terrific. Hopefully schedules align and you are able to attend. TIA.
Well counts are increasing at a healthy pace. There are many, many tens of thousands additional wells that could benefit by use of IEVM's product. The greatest challenge facing the company now is keeping up with demand as well counts explode. Build more depots!
Love today's volume.
Bingo! Post of the day.
Thanks for another informative and well formulated post.
Successful comedy and successful investing, the secret to both is timing. $2.63 is short term noise. Can you wait for the punchline?